Literature DB >> 3790479

Ophthalmic survey of a diabetic clinic. I: Ocular findings.

R H Grey, N Malcolm, D O'Reilly, A Morris.   

Abstract

A medical diabetic clinic was examined for evidence of diabetic eye disease. Of 681 patients invited for ocular examination 96.6% attended for screening. The results for insulin dependent diabetics (IDDs) and non-insulin dependent diabetics (NIDDs) were analysed separately and the major findings were: Cataracts were present in 40.8% of IDDs and 46.2% of NIDDs, with an increased incidence with advancing age. For younger age groups there were significantly more cataracts in IDDs than in NIDDs (p less than 0.001). Cataract extraction was required in 4.2% of the patients, which is higher than the general population. The presence of retinopathy was related to the duration of diabetes (p less than 0.001) but not to age of onset of diabetes. Retinopathy was found in 43.4% of IDDs and 20.1% of NIDDs. Sight threatening retinopathy was present in 13.3% of IDD and 4.3% of NIDD eyes. Advanced diabetic eye disease was seen in 0.6% of eyes.

Entities:  

Mesh:

Year:  1986        PMID: 3790479      PMCID: PMC1040831          DOI: 10.1136/bjo.70.11.797

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  CATARACT EXTRACTION IN AN ENGLISH POPULATION.

Authors:  F I CAIRD; M HUTCHINSON; A PIRIE
Journal:  Br J Prev Soc Med       Date:  1965-04

2.  Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser.

Authors:  B L Hercules; I I Gayed; S B Lucas; J Jeacock
Journal:  Br J Ophthalmol       Date:  1977-09       Impact factor: 4.638

3.  The natural history of diabetic retinopathy.

Authors:  A G Burditt; F I Caird; G J Draper
Journal:  Q J Med       Date:  1968-04

4.  Diabetic blindness and its prevention by photocoagulation.

Authors:  A M Hamilton
Journal:  Trans Ophthalmol Soc U K       Date:  1978

5.  Prevalence of diabetic retinopathy. Age, sex, and duration of diabetes.

Authors:  H A Kahn; R F Bradley
Journal:  Br J Ophthalmol       Date:  1975-07       Impact factor: 4.638

6.  Vitrectomy for complications of diabetic retinopathy.

Authors:  R G Michels
Journal:  Arch Ophthalmol       Date:  1978-02

7.  Response of proliferative diabetic retinopathy to xenon-arc photocoagulation. A multicentre randomized controlled trial. Second interim report.

Authors:  H Cheng
Journal:  Trans Ophthalmol Soc U K       Date:  1976-07

8.  Optic disc neovascularisation in diabetic retinopathy: II. Natural history and results of photocoagulation treatment.

Authors:  Y Yassur; L W Pickle; S L Fine; L Singerman; D H Orth; A Patz
Journal:  Br J Ophthalmol       Date:  1980-02       Impact factor: 4.638

9.  Clinical results in vitrectomy for diabetic traction retinal detachment.

Authors:  T M Aaberg
Journal:  Am J Ophthalmol       Date:  1979-08       Impact factor: 5.258

10.  Hemoglobin A1 and diabetic retinopathy.

Authors:  D J Schanzlin; W H Jay; K J Fritz; R C Tripathi; B Gonen
Journal:  Am J Ophthalmol       Date:  1979-12       Impact factor: 5.258

View more
  5 in total

1.  Ophthalmic survey of a diabetic clinic.

Authors:  I Rosenblat; R David; Y Yassur
Journal:  Br J Ophthalmol       Date:  1988-02       Impact factor: 4.638

2.  A vitreoretinal service.

Authors:  J Richardson; C M Wood; L J Mackay; E S Gardner
Journal:  BMJ       Date:  1989-07-22

3.  Ophthalmic survey of a diabetic clinic: II. Requirements for treatment of retinopathy.

Authors:  R H Grey; A Morris
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

4.  The transparency of the lens: a comparison between diabetic and non-diabetic patients.

Authors:  S L Franklin; J Flammer; R De Natale; C Rutishuser
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

5.  Blind and partial sight registration in Avon.

Authors:  R H Grey; C J Burns-Cox; A Hughes
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.